HDFC Life Insurance decreased its stake in Alkem Laboratories from 1.31% to 1.17%, selling 1,63,371 shares.
A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.
HDFC Life Insurance Company Limited, institutional investor in Indian equities
